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Objectives: To describe the characteristics and outcomes of 
patients with acute respiratory distress syndrome with or without 
spontaneous breathing and to investigate whether the effects of 
spontaneous breathing on outcome depend on acute respiratory 
distress syndrome severity.
Design: Planned secondary analysis of a prospective, observa-
tional, multicentre cohort study.
Setting: International sample of 459 ICUs from 50 countries.
Patients: Patients with acute respiratory distress syndrome and at 
least 2 days of invasive mechanical ventilation and available data 
for the mode of mechanical ventilation and respiratory rate for the 
2 first days.
Interventions: Analysis of patients with and without spontaneous 
breathing, defined by the mode of mechanical ventilation and by 
actual respiratory rate compared with set respiratory rate during 
the first 48 hours of mechanical ventilation.
Measurements and Main Results: Spontaneous breathing was 
present in 67% of patients with mild acute respiratory distress 
syndrome, 58% of patients with moderate acute respiratory dis-
tress syndrome, and 46% of patients with severe acute respira-
tory distress syndrome. Patients with spontaneous breathing were 
older and had lower acute respiratory distress syndrome severity, 
Sequential Organ Failure Assessment scores, ICU and hospital 
mortality, and were less likely to be diagnosed with acute respiratory 
distress syndrome by clinicians. In adjusted analysis, spontaneous 
breathing during the first 2 days was not associated with an effect 
on ICU or hospital mortality (33% vs 37%; odds ratio, 1.18 [0.92–
1.51]; p = 0.19 and 37% vs 41%; odds ratio, 1.18 [0.93–1.50]; p = 
0.196, respectively ). Spontaneous breathing was associated with 
increased ventilator-free days (13 [0–22] vs 8 [0–20]; p = 0.014) 
and shorter duration of ICU stay (11 [6–20] vs 12 [7–22]; p = 0.04).
Conclusions: Spontaneous breathing is common in patients with 
acute respiratory distress syndrome during the first 48 hours of 
mechanical ventilation. Spontaneous breathing is not associated 
with worse outcomes and may hasten liberation from the ventilator 
and from ICU. Although these results support the use of spontane-
ous breathing in patients with acute respiratory distress syndrome 
independent of acute respiratory distress syndrome severity, the use 
of controlled ventilation indicates a bias toward use in patients with 
higher disease severity. In addition, because the lack of reliable data 
on inspiratory effort in our study, prospective studies incorporating 
the magnitude of inspiratory effort and adjusting for all potential sever-
ity confounders are required. (Crit Care Med 2019; 47:229–238)
Key Words: acute respiratory distress syndrome; controlled 
mechanical ventilation; spontaneous breathing; supported ventilation
In patients with acute respiratory distress syndrome (ARDS), lung protective mechanical ventilation (MV) is used to avoid ventilator-induced lung injury by limiting 
volume and pressure (1, 2). Patient spontaneous breathing 
(SB) activity may impede efforts to limit tidal volume (Vt) and 
suppressing SB with early neuromuscular blockade improves 
outcomes in patients with severe ARDS (3).
The use of partially supported breathing modes is increas-
ing, but there is much uncertainty about its effects (4–6). SB 
has been shown to improve gas exchange, hemodynamics 
and nonpulmonary organ perfusion and function, is associ-
ated with reduced sedation, and may prevent disuse and loss 
of peripheral muscle and diaphragm function (7–10). Partially 
supported MV better resembles natural respiratory variability 
when compared with controlled MV (5, 11), improves lung 
mechanics and enhances tidal distribution to the dependent 
regions of the lung (12), reducing shunt and decreasing dead 
space (13). However, SB in MV may cause or worsen acute lung 
injury if ARDS is severe and spontaneous effort is vigorous (14, 
15). SB contributes to the transpulmonary pressure (11) and 
may cause unsuspected overstretch of dependent lung during 
early inflation even when not increasing Vt (16).
The objective of this planned sub-study of the Large obser-
vational study to UNderstand the Global impact of Severe 
Acute respiratory FailurE (LUNG SAFE) is to describe the 
characteristics and outcomes of patients with SB compared 
with patients with no SB during the first days of ARDS, and 
to investigate whether the effects of SB on outcome depend on 
the severity of ARDS.
PATIENTS AND METHODS
Study Design
Prospective, observational, international multicentre cohort 
study in 13,751 ventilated patients in 459 ICUs from 50 coun-
tries. The detailed study design and main results have been 
published previously (17). All participating ICUs obtained 
ethics committee approval, and either patient consent or ethics 
committee waiver of consent.
Data Collection
Data on arterial blood gases, mode and settings of ventilatory 
support, and Sequential Organ Failure Assessment (SOFA) 
score were collected on selected days during the ICU stay until 
day 28, ICU discharge, or death, whichever came first. Data on 
ventilatory settings were recorded simultaneously with arterial 
blood gas analysis. ICU and hospital survival were collected at 
the time of discharge and censored at 90 days after enrollment. 
We assessed clinician recognition of ARDS on day 1 of study 
entry, and when patients exited the study (17).
Patient Cohorts and Definitions
Patients receiving MV during the study period were enrolled. 
Exclusion criteria were age less than 16 years or inability to 
obtain informed consent if required. For the current study, we 
restricted analyses to the subset of patients with ARDS (18) on 
Clinical Investigations
Critical Care Medicine www.ccmjournal.org 231
day 1 or day 2 following the onset of acute hypoxemic respira-
tory failure (AHRF), who had at least 2 days of MV and avail-
able data for the mode of MV and respiratory rate (RR) for the 
2 first days.
Patients were divided into two groups: patients with no 
SB activity (controlled, C group) and patients with SB activ-
ity (SB group). Patients were included in the C group if they 
received controlled mode ventilation with a set RR equal to the 
actual RR on both day 1 and 2 (actual RR = set RR); patients 
were included in the SB group if they received a mode of MV 
with no mandatory breaths (i.e., pressure support ventilation 
(PSV), proportional assist ventilation (PAV), continuous posi-
tive airway pressure (CPAP)) on day 1 and/or day 2 or if they 
received an assist control mode of ventilation and their actual 
RR was greater than the set RR on day 1 and/or day 2.
To perform additional analyses and decrease heterogeneity 
in the SB group, we divided the SB group into a fully SB (SB-
F) group and a partially SB (SB-P) group. Patients in the SB-F 
group had SB without any controlled or mandatory breaths 
(i.e., PSV, PAV, CPAP) on both day 1 and 2. All other patients 
with SB were included in the SB-P group.
For our primary analysis, we compared characteristics and 
outcomes of patients in the C group with patients in the SB 
group, stratified by ARDS severity based on the Pao
2
/Fio
2
 ratio. 
We performed additional analyses by comparing the C group 
with the SB-F group and with the SB-P group, by comparing 
survivors with nonsurvivors, and by propensity scoring match-
ing analysis.
Statistical Analysis
For quantitative variables collected on day 1 and day 2, we cal-
culated the mean value of the 2 days or used the available value 
if one of the two values was missing. Continuous variables are 
reported as mean ± sd or median (first–third quartiles) and 
categorical variables as count and proportion. Comparisons of 
proportions were made using chi-square or Fisher exact tests. 
Continuous variables were compared using Student t test or 
Wilcoxon rank-sum test when two groups were compared, and 
corresponding paired tests for matched patients, as appropri-
ate. Comparing continuous variables for three groups, we used 
analysis of variance or Kruskal-Wallis tests. Tukey range tests 
were used to compare all possible pairs of means within the 
three groups.
We performed bivariate analyses to identify factors poten-
tially associated with hospital mortality, assuming that patients 
discharged alive from hospital before 90 days were alive on day 
90. Covariates found to be associated with hospital mortality 
in the bivariate analysis with a p value of less than or equal to 
0.20 were entered in stepwise (forward and backward) mul-
tivariable logistic regression analyses with significance alpha 
levels less than or equal to 0.05 for retention. MV (C or SB) 
was forced in the model as it was the main focus of this study. 
In addition, the Pao
2
/Fio
2
 ratio was included in the model to 
assess whether the effects of SB on outcome depend on ARDS 
severity. Results are shown as odds ratios (ORs) with 95% CI 
and as beta coefficient with se.
As a sensitivity analysis, we used a propensity approach to 
control for observed confounding factors that might influence 
MV group or hospital mortality. We estimated the propensity 
score of having no SB in the first 2 days of ARDS using a logis-
tic regression model including potential predictors (detailed in 
eTables 4-8, Supplemental Digital Content 2, http://links.lww.
com/CCM/E147). Missing data were imputed with chained 
equation, where missing variables for each patient were aver-
aged across 30 completed datasets. Patients from the C group 
were matched with patients from the SB group, using a 1:1 
matching procedure without replacement and caliper width of 
0.2, as recommended (19). Similarly, patients from the C group 
were matched with patients from the SB-F group to overcome 
heterogeneity in the SB group. Balances in confounders before 
and after matching were checked using standardized mean dif-
ferences. No assumptions were made for missing data apart 
for the propensity score, and we followed the Strengthening 
the Reporting of Observational Studies in Epidemiology rec-
ommendations (20). Statistical analysis was performed with 
R (Version 3.3.3; R Foundation for Statistical Computing, 
Vienna, Austria). All p values were two-sided, and values less 
than 0.05 were deemed significant.
RESULTS
Prevalence of SB Activity
Of 12,906 patients screened for the LUNG SAFE study, 2,813 
patients fulfilled ARDS criteria within 2 days of AHRF onset 
(Fig. 1). Of these, 1,756 patients had at least 2 days of MV and 
available data for the mode of MV and RR for the 2 first days. 
Seven-hundred forty patients had no SB during the first 2 days 
(C group, 42%) and 1,016 patients had SB (SB group, 58%), 
with 180 patients without any controlled or mandatory breaths 
on both day 1 and 2 (SB-F group, 10%). The distribution of 
ventilatory modes on day 1 and 2 in patients in the SB-P group 
is shown in eFigure 1 (Supplemental Digital Content 2, http://
links.lww.com/CCM/E147).
Stratified by ARDS severity, SB was present in 67% of patients 
(344/515) with mild ARDS, 58% of patients (488/844) with mod-
erate ARDS, and 46% of patients (184/397) with severe ARDS.
Demographic and Clinical Characteristics
Patients in the SB group were older and had significantly 
lower ARDS severity, SOFA scores and nonpulmonary SOFA 
scores (Table 1). There were no differences in comorbidities 
or admission type between groups. Risk factors for ARDS were 
similar, except for nonpulmonary sepsis, which was higher in 
the SB group. SB was associated with more ICU beds and with 
a lower physician-to-bed, but a higher nurse-to-bed ratio. Cli-
nician recognition of ARDS at any time during the study, but 
not at baseline, was lower in the SB group.
After stratification by Pao
2
/Fio
2
 ratio less than 150, or 
greater than or equal to 150, age and body weight were similar 
in both groups (Table 1). Patients in the SB group had lower 
SOFA and nonpulmonary SOFA scores in both strata, indicat-
ing that they were less sick. Patients in the SB group with Pao
2
/
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Fio
2
 ratio greater than or equal to 150 were less likely to be 
diagnosed with ARDS by the clinician compared with patients 
in the C group. SB patients in both strata were less likely to 
have received sedation and lung recruitment maneuvers in the 
first 48 hours.
The demographic and clinical characteristics of the C and 
SB groups, stratified to ARDS severity mild, moderate, and 
severe are shown in eTable 1 (Supplemental Digital Content 2, 
http://links.lww.com/CCM/E147).
Ventilation and Physiologic Variables
Mean Vt were higher in patients with SB (7.9 ± 1.7 vs 
7.5 ± 1.5 mL/kg predicted body weight (PBW); p < 0.001) 
(Table 2). In the SB group, 60% of patients received a Vt 
of 8 mL/kg of PBW or less; 
this was 68% in the C group 
(p < 0.001) (Fig. 2A). Plateau 
pressures, peak inspiratory 
pressures, and levels of posi-
tive end-expiratory pressure 
(PEEP) were significantly 
lower in the SB group (Table 2; 
and Fig. 2, B and C). Among 
the 683 patients with available 
data both for plateau pres-
sure and Vt, 69% in the SB 
group and 65% in the C group 
(p = 0.354) fell within the lim-
its for protective ventilation 
(defined as plateau pressure 
≤ 30 cm H
2
O and Vt ≤ 8mL/kg 
PBW) (Fig. 3). Despite lower 
levels of standardized minute 
ventilation in the SB group, 
Paco
2
 levels were lower and pH 
higher. The differences in Vt, 
PEEP, peak pressures, Paco
2
 
levels, and pH remained sig-
nificant after stratification by 
Pao
2
/Fio
2
 ratio (Table 2).
Ventilation and physi-
ologic variables of the C and 
SB groups stratified to ARDS 
severity mild, moderate, and 
severe are shown in eTable 1 
(Supplemental Digital Content 
2, http://links.lww.com/CCM/
E147).
Clinical Outcomes in 
Unadjusted Analyses
The SB group had significantly 
shorter duration of MV, higher 
number of ventilator-free days 
(VFDs), and shorter stay in the 
ICU than the C group. ICU 
and hospital mortality were lowest in the SB group (Table 2). 
When stratified by Pao
2
/Fio
2
 ratio, patients in the SB group had 
more VFD and lower ICU mortality in both strata. ICU length 
of stay (LOS) was shorter only in the SB group when Pao
2
/Fio
2
 
ratio less than 150. There were no differences in rates of life-
sustaining therapies limitation decisions between the groups. 
Clinical outcomes, stratified by ARDS severity mild, moderate, 
and severe is shown in eTable 1 (Supplemental Digital Content 
2, http://links.lww.com/CCM/E147).
Additional and Adjusted Analyses
Patients in the SB-F group had lower SOFA scores, lower ARDS 
severity and were less likely to be diagnosed with ARDS both 
on day 1 and at any time than patients in the SB-P or the C 
Figure 1. Flowchart of the study population. AHRF = acute hypoxemic respiratory failure, ARDS = acute 
respiratory distress syndrome, ECMO = extracorporeal membrane oxygenation, HFO = high-frequency 
oscillation ventilation, LUNG SAFE = Large observational study to UNderstand the Global impact of Severe 
Acute respiratory FailurE, MV = mechanical ventilation, NIV = noninvasive ventilation, SB = spontaneous 
breathing, SB-F = fully SB, SB-P = partially SB. Group C represent controlled group.
Clinical Investigations
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TABLE 1. Characteristics of Patients With Acute Respiratory Distress Syndrome 
With Spontaneous Breathing Activity (Spontaneous Breathing Group) and Without 
Spontaneous Breathing Activity (C group), Stratified by Pao2/Fio2 Ratio
Characteristics
Pao2:Fio2 ratio ≥ 150, n = 908 Pao2:Fio2 ratio < 150, n = 848 ARDS, All, n = 1,756
Patients With 
SB Activity  
(SB Group),  
n = 584
Patients With  
No SB Activity 
(C Group),  
n = 324
Patients With 
SB Activity  
(SB Group),  
n = 432
Patients With  
No SB Activity 
(C Group),  
n = 416
Patients With 
SB Activity  
(SB Group),  
n = 1016
Patients With  
No SB Activity 
(C Group),  
n = 740 p
Age, yr, mean (sd) 62.6 ± 16.7 60.4 ± 17.3 59.8 ± 16.7 59.4 ± 16.9 61.4 (16.8) 59.8 (17.1) 0.048
Males, n (%) 357 (61.1) 201 (62.0) 285 (66.0) 262 (63.0) 642 (63.2) 463 (62.6) 0.829
Height, cm, mean (sd) 167.8 ± 10.1 168.3 ± 9.7 168.0 ± 10.0 168.8 ± 9.8 167.9 ± 10.0 168.6 ± 9.8 0.170
Weight, kg, mean (sd) 75.4 ± 19.8 77.7 ± 20.0 78.0 ± 32.8 80.7 ± 22.2 76.6 (26.2) 79.4 (21.3) 0.015
SOFA score day 1, mean (sd) 9.0 ± 3.7 10.0 ± 3.6a 10.4 ± 3.7 11.1 ± 4.2a 9.8 (3.8) 10.6 (4.0) < 0.001
Nonpulmonary SOFA score  
day 1, mean (sd)
6.4 ± 3.8 7.3 ± 3.7a 6.7 ± 3.7 7.3 ± 4.1a 6.6 (3.7) 7.3 (4.0) < 0.001
Chronic disease, n (%)
 Diabetes 130 (22.3) 82 (25.3) 93 (21.5) 97 (23.3) 223 (21.9) 179 (24.2) 0.296
 Chronic obstructive 
pulmonary disease
121 (20.7) 61 (18.8) 88 (20.4) 98 (23.6) 209 (20.6) 159 (21.5) 0.685
 Chronic renal failure 64 (11.0) 35 (10.8) 34 (7.9) 32 (7.7) 98 (9.6) 67 (9.1) 0.736
 Neoplasm or 
immunosuppression
119 (20.4) 59 (18.2) 99 (22.9) 79 (19.0) 218 (21.5) 138 (18.6) 0.166
 Chronic heart failure 52 (8.9) 30 (9.3) 43 (10.0) 39 (9.4) 95 (9.4) 69 (9.3) 1.000
 Chronic liver failure 26 (4.5) 12 (3.7) 19 (4.4) 20 (4.8) 45 (4.4) 32 (4.3) 1.000
 Home ventilation 13 (2.2) 3 (0.9) 7 (1.6) 5 (1.2) 20 (2.0) 8 (1.1) 0.203
Admission type, n (%)       0.115
 Medical 408 (69.9) 221 (68.2) 337 (78.0) 337 (81.0) 745 (73.3) 558 (75.4)  
 Surgical (postoperative 
elective)
45 (7.7) 19 (5.9) 22 (5.1) 18 (4.3) 67 (6.6) 37 (5.0)  
 Surgical 108 (18.5) 62 (19.1%) 59 (13.7) 44 (10.6) 167 (16.4) 106 (14.3)  
 Trauma 23 (3.9) 22 (6.8%) 14 (3.2) 17 (4.1) 37 (3.6) 39 (5.3)  
Risk factor for ARDS, n (%)
 Pneumonia 315 (53.9) 165 (50.9) 277 (64.1) 263 (63.2) 592 (58.3) 428 (57.8) 0.857
 Nonpulmonary sepsis 125 (21.4) 56 (17.3) 70 (16.2) 55 (13.2) 195 (19.2) 111 (15.0) 0.022
 Aspiration 88 (15.1) 67 (20.7)a 74 (17.1) 71 (17.1) 162 (15.9) 138 (18.6) 0.139
 Trauma 30 (5.1) 25 (7.7) 25 (5.8) 19 (4.6) 55 (5.4) 44 (5.9) 0.632
 Inhalation 15 (2.6) 9 (2.8) 11 (2.5) 14 (3.4) 26 (2.6) 23 (3.1) 0.493
 Pancreatitis 12 (2.1) 8 (2.5) 12 (2.8) 10 (2.4) 24 (2.4) 18 (2.4) 0.919
 Burns 1 (0.2) 1 (0.3%) 4 (0.9) 0 (0.0) 5 (0.5) 1 (0.1) 0.238
 Pulmonary vasculitis 4 (0.7) 6 (1.9) 4 (0.9) 8 (1.9) 8 (0.8) 14 (1.9) 0.046
 Noncardiogenic shock 49 (8.4) 31 (9.6) 32 (7.4) 29 (7.0) 81 (8.0) 60 (8.1) 0.989
 Overdose 13 (2.2) 7 (2.2) 8 (1.9) 10 (2.4) 21 (2.1) 17 (2.3) 0.742
 Transfusion-related acute 
lung injury
26 (4.5) 15 (4.6) 15 (3.5) 23 (5.5) 41 (4.0) 38 (5.1) 0.276
 Number of ICU beds,  
median (IQR)
18.0  
(12.0–26.0)
16.0  
(10.0–24.0)a
16.0  
(10.0–25.0)
16.0  
(10.0–22.8)
18.0  
(12.0–26.0)
16.0  
(10.0–23.0)
0.003
 Number of patients/staff 
physician, median (IQR)
6.0  
(2.7–10.6)
4.5  
(2.6–8.5)a
5.0  
(2.8–11.0)
3.8  
(2.4–8.0)a
5.4  
(2.8–11.0)
4.0  
(2.5–8.1)
< 0.001
(Continued )
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group (eTable 2, Supplemental Digital Content 2, http://links.
lww.com/CCM/E147). Both ICU and hospital mortality were 
lowest in the SB-F group. Of patients in the SB-F group, 22% 
changed to either being in the SB-P or in the C group. Patients 
who changed had a higher hospital mortality rate compared 
with patients who continued to be in the SB-F group (53% vs 
32%; p = 0.032), but with similar rates of clinician recognition 
of ARDS (58% vs 49%; p = 0.460).
Characteristics of survivors compared with nonsurvivors are 
shown in eTable 3 (Supplemental Digital Content 2, http://links.
lww.com/CCM/E147). Vt was not different between survivors 
and nonsurvivors in all patients with ARDS, and when strati-
fied by ARDS severity (eFig. 2, Supplemental Digital Content 
2, http://links.lww.com/CCM/E147). The following factors 
were associated with increased mortality: older age, lower body 
weight, type of admission, active neoplasm, chronic liver failure, 
higher SOFA scores, and ARDS severity. Potentially modifiable 
factors included higher peak inspiratory and plateau pressures 
and increased RR. In a multivariable logistic regression model, 
after adjusting for covariates significantly associated with out-
come, SB was not independently associated with ICU mortality 
(OR, 1.17; 95% CI, 0.92–1.49; p = 0.208) or hospital mortal-
ity (OR, 1.13; 95% CI, 0.92–1.50; p = 0.298) (eTables 4 and 5, 
Supplemental Digital Content 2, http://links.lww.com/CCM/
E147). When limiting the multivariable logistic regression anal-
ysis to patients with Pao
2
/Fio
2
 ratio less than 150 or greater than 
or equal to 150, SB was not independently associated with hos-
pital mortality (eTables 6 and 7, Supplemental Digital Content 
2, http://links.lww.com/CCM/E147). The Pao
2
/Fio
2
 ratio did 
not independently affect the outcomes of SB on hospital mor-
tality (interaction term Pao
2
/Fio
2
 ratio × no SB: beta coefficient 
–0.003; se 0.018; p = 0.865) (eTable 8, Supplemental Digital 
Content 2, http://links.lww.com/CCM/E147).
For sensitivity analysis by propensity score matching, we 
matched 555 of 740 patients (75%) in the C group with 555 of 
1,016 patients (55%) in the SB group (eTable 9, Supplemental 
Digital Content 2, http://links.lww.com/CCM/E147). Missing 
data are shown in eTable 10 (Supplemental Digital Content 2, 
http://links.lww.com/CCM/E147). The two groups were well 
matched on demographic characteristics, comorbidities, and 
SOFA (eTable 9 and eFig. 3, Supplemental Digital Content 2, 
http://links.lww.com/CCM/E147). After matching there was no 
significant difference in ICU and hospital mortality rates, but 
the SB group had more VFD (13 [0–22] vs 8 [0–20]; p = 0.014) 
and shorter ICU LOS (11 [6–20] vs 12 [7–22]; p = 0.04). When 
adjusting the model by removing variables potentially related to 
the ventilatory mode (peak inspiratory pressure, RR, minute ven-
tilation, Vt, Pco
2
), we matched 668 patients. This modification 
did not change the results (eTable 11 and eFig. 4, Supplemental 
Digital Content 2, http://links.lww.com/CCM/E147).
For sensitivity analysis by propensity score matching, we also 
matched 89 of 740 patients (12%) in the C group with 89 of 180 
patients (49%) in the SB-F group. (eTable 12, Supplemental 
Digital Content 2, http://links.lww.com/CCM/E147). The two 
groups were well matched on demographic characteristics, comor-
bidities, and SOFA (eTable 12 and eFig. 5, Supplemental Digital 
Content 2, http://links.lww.com/CCM/E147). After matching 
there was no significant difference in any of the outcomes. When 
Number of patients/nurse, 
median (IQR)
1.4 (1.0–2.0) 1.5 (1.0–2.1) 1.3 (1.0–2.0) 1.6 (1.0–2.2)a 1.4 (1.0–2.0) 1.5 (1.0–2.2) 0.019
Clinician recognition of ARDS, n (%)
 On first day of ARDS 161 (27.6) 101 (31.2) 160 (37.0) 162 (38.9) 321 (31.6) 263 (35.5) 0.093
 At any time 317 (54.3) 200 (61.7)a 305 (70.6) 318 (76.4) 622 (61.2) 518 (70.0) < 0.001
Treatment adjuncts in first 48 hr, n (%)
 Sedation 439 (75.2) 287 (88.6)a 348 (80.6) 390 (93.8)a 787 (77.5) 677 (91.5) < 0.001
 Neuromuscular blockade 41 (7.0) 43 (13.3)a 51 (11.8) 144 (34.6)a 92 (9.1) 187 (25.3) < 0.001
 Prone positioning 8 (1.4) 10 (3.1) 16 (3.7) 48 (11.5)a 24 (2.4) 58 (7.8) < 0.001
 Lung recruitment 
manoeuvres
62 (10.6) 53 (16.4)a 91 (21.1) 113 (27.2)a 153 (15.1) 166 (22.4) < 0.001
 Tracheostomy at any time 83 (14.2) 45 (13.9) 54 (12.5) 51 (12.3) 137 (13.5) 96 (13.0) 0.810
ARDS = acute respiratory distress syndrome, IQR = interquartile range, SB = spontaneous breathing, SOFA = Sequential Organ Failure Assessment.
a p < 0.05 C group vs SB group.
TABLE 1. (Continued). Characteristics of Patients With Acute Respiratory Distress 
Syndrome With Spontaneous Breathing Activity (Spontaneous Breathing Group) and 
Without Spontaneous Breathing Activity (C group), Stratified by Pao2/Fio2 Ratio
Characteristics
Pao2:Fio2 ratio ≥ 150, n = 908 Pao2:Fio2 ratio < 150, n = 848 ARDS, All, n = 1,756
Patients With 
SB Activity  
(SB Group),  
n = 584
Patients With  
No SB Activity 
(C Group),  
n = 324
Patients With 
SB Activity  
(SB Group),  
n = 432
Patients With  
No SB Activity 
(C Group),  
n = 416
Patients With 
SB Activity  
(SB Group),  
n = 1016
Patients With  
No SB Activity 
(C Group),  
n = 740 p
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adjusting the model by removing variables potentially related to 
the ventilatory mode (peak inspiratory pressure, RR, minute ven-
tilation, Vt, Pco
2
), we matched 166 patients. This modification 
did not change the results (eTable 13 and eFig. 6, Supplemental 
Digital Content 2, http://links.lww.com/CCM/E147).
DISCUSSION
In this LUNG SAFE ancillary study, we examined the current 
practice and outcomes of SB in ARDS. Patients with SB were 
older and less sick, had lower ventilatory pressures with higher 
pH and lower Paco
2
, despite similar standardized minute ven-
tilation and independent of ARDS severity. Vt was higher in 
SB patients, but the absolute difference was small and unlikely 
to be clinically meaningful. After adjustment for covariates and 
propensity matching which included measures of severity of 
disease, there was no difference in hospital mortality between 
the groups, but patients with SB had more VFDs and shorter 
ICU LOS. Patients with SB had less exposure to sedation than 
TABLE 2. Ventilation, Physiologic, and Outcome Variables of Patients With Acute 
Respiratory Distress Syndrome With Spontaneous Breathing Activity (Spontaneous 
Breathing Group) and Without Spontaneous Breathing Activity (C group), Stratified by 
Pao2/Fio2 Ratio
Variables
Pao2:Fio2 ratio ≥ 150,  
n = 908
Pao2:Fio2 ratio < 150,  
n = 848
Acute Respiratory Distress  
Syndrome, All, n = 1,756
Patients With 
SB  
Activity  
(SB Group)
Patients  
With No SB  
Activity  
(C Group)
Patients  
With SB  
Activity  
(SB Group)
Patients  
With No SB  
Activity  
(C Group)
Patients  
With SB  
Activity  
(SB Group)
Patients  
With No SB  
Activity  
(C Group) p
Fio2, median (IQR) 0.4  
(0.4–0.5)
0.5  
(0.4–0.6)a
0.6  
(0.6–0.8)
0.7  
(0.6–0.8)a
0.5  
(0.4–0.7)
0.6  
(0.5–0.8)
< 0.001
Respiratory rate (actual), mean (sd) 20.2 ± 5.3 19.2 ± 4.9a 22.1 ± 5.5 21.4 ± 5.4 21.0 (5.5) 20.4 (5.3) 0.024
Tidal volume, mL/kg predicted body 
weight, mean (sd)
7.9 ± 1.8 7.6 ± 1.5a 7.8 ± 1.7 7.5 ± 1.5a 7.9 (1.7) 7.5 (1.5) < 0.001
Minute ventilation, L/min, mean (sd) 9.86 ± 3.43 9.79 ± 3.28 11.60 ± 4.02 11.96 ± 4.94 10.59 (3.79) 11.01 (4.43) 0.038
Positive end-expiratory pressure, cm 
H2O, mean (sd)
7.4 ± 2.6 8.0 ± 2.7a 8.8 ± 2.8 9.5 ± 3.3a 8.0 (2.7) 8.9 (3.1) < 0.001
Peak pressure, cm H2O, mean (sd) 23.4 ± 6.8 28.0 ± 8.0
a 25.9 ± 6.8 30.9 ± 6.8a 24.5 (6.9) 29.6 (7.5) < 0.001
Plateau pressure, cm H2O
b, mean (sd) 20.9 ± 5.3 22.2 ± 5.0a 24.0 ± 5.8 24.8 ± 5.8 22.2 (5.7) 23.8 (5.7) < 0.001
Compliance, mL/cm H2O
c, mean (sd) 37.8 ± 15.0 36.1 ± 14.5 33.5 ± 14.1 33.4 ± 14.0 36.0 (14.8) 34.5 (14.3) 0.161
Peripheral oxygen saturation, median 
(IQR)
97.0  
(95.5–98.5)
97.0  
(95.9–98.5)
95.0  
(92.5–97.0)
95.0  
(93.0–97.0)
96.5  
(94.5–98.0)
96.0  
(94.0–98.0)
0.307
Paco2, mm Hg, mean (sd) 38.0 ± 10.9 40.1 ± 12.9
a 41.1 ± 13.1 44.1 ± 16.4a 39.3 (11.9) 42.4 (15.0) < 0.001
pH, mean (sd) 7.37 ± 0.08 7.34 ± 0.09a 7.35 ± 0.10 7.31 ± 0.11a 7.36 (0.09) 7.32 (0.10) < 0.001
Duration of mechanical ventilation, 
median (IQR), d
8.0  
(4.0–14.0)
9.0  
(5.0–14.8)
8.0  
(4.0–15.0)
11.0  
(6.0–19.0)a
8.0  
(4.0–14.0)
10.0  
(5.0–17.0)
< 0.001
Invasive ventilation free-days to day 
28, median (IQR), d
16.0  
(0.0–23.0)
10.5  
(0.0–21.0)a
12.0  
(0.0–21.0)
0.0  
(0.0–18.0)a
15.0  
(0.0–22.0)
5.5  
(0.0–19.0)
< 0.001
ICU length of stay, median (IQR), d 11.0  
(6.0–19.0)
11.0  
(6.0–20.0)
11.0  
(6.0–19.0)
13.0  
(7.0–23.0)a
11.0  
(6.0–19.0)
12.0  
(7.0–22.0)
0.012
Hospital length of stay,  
median (IQR), d
19.0  
(10.0–35.0)
17.0  
(9.0–35.0)
17.0  
(8.0–30.0)
20.0  
(10.0–34.0)
18.0  
(9.0–33.0)
19.0  
(9.0–35.0)
0.414
ICU mortality, n (%) 168 (28.8) 115 (35.5)a 149 (34.5) 173 (41.6)a 317 (31.2) 288 (38.9) 0.001
Hospital mortality, n (%) 206 (35.5) 135 (41.7) 171 (39.6) 184 (44.7) 377 (37.3) 319 (43.3) 0.012
Treatment limitations, n (%) 130 (22.3) 89 (27.5) 111 (25.7) 98 (23.6) 241 (23.7) 187 (25.3) 0.455
IQR = interquartile range, SB = spontaneous breathing.
a p < 0.05 C group vs SB group.
b Data for plateau pressure was available for 431 patients in the SB group and 402 in the C group.
c Data for compliance was available for 429 patients in the SB group and 400 in the C group.
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patients on controlled MV, which could be a factor contribut-
ing to the difference in VFDs and ICU LOS.
These findings need to be interpreted with caution. We 
did not assess the potential for patient-ventilator asynchrony. 
Asynchronies are common, occur in all modes of MV and are 
associated with worse outcome (21, 22). The SB group was 
heterogeneous and included different MV modes. Different 
modes that allow SB may have 
different effects on lung aera-
tion (23). When limiting the 
analysis to patients who had 
only spontaneous (SB-F) ver-
sus only controlled (C) breath-
ing on the first 2 days after 
ARDS onset, there was also no 
difference in hospital mortal-
ity between the groups. The 
size estimate and direction of 
the effect of SB-F compared 
with C on VFD and ICU LOS 
appeared similar to the main 
analysis but was no longer sta-
tistically significant, most likely 
because of the reduced power 
in the smaller sample size.
Patients without SB con-
stituted a more severe group 
of patients, which could 
explain why clinicians initi-
ate controlled ventilation. 
This statement is supported 
by our finding that patients 
on controlled ventilation were 
more likely to be diagnosed 
with ARDS by the clinician. 
Consistent with our findings 
in patients managed with NIV 
(24), patients who “failed” SB-F 
and were switched to SB-P or 
controlled ventilation at any 
time after the first 2 days, had a 
higher mortality.
Previous studies have sug-
gested that the effects of SB 
during MV in ARDS may 
depend on ARDS etiology and 
severity, with possible benefi-
cial effects in mild to moderate 
ARDS and harmful effects in 
severe ARDS (25–27). We did 
not find an association between 
ARDS severity, or etiology, and 
outcomes in patients with or 
without SB.
We did not find a significant 
effect of Vt on mortality. We 
believe this analysis is confounded by the absence of good indi-
cators for inspiratory effort in SB patients in this study. Large 
Vt during SB in ARDS patients may indicate a high inspiratory 
effort or less severe ARDS with a more compliant respiratory 
system. Our results indicate that the level of inspiratory effort 
in patients on MV cannot be reliably predicted from either the 
ventilatory mode, Vt, or RR. However, from our data, it seems 
Figure 2. A, Cumulative frequency distribution of the mean tidal volume of day 1 and 2. B, Cumulative 
frequency distribution of the mean plateau pressure of day 1 and 2. C, Cumulative frequency distribution of the 
mean peak inspiratory pressure of day 1 and 2. PBW = predicted body weight, SB = spontaneous breathing. C 
group represent patients with no SB activity and SB group represent patients with SB activity.
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that large inspiratory efforts with SB are either infrequent or 
not “excessive” (at population level) when clinicians are free to 
choose the ventilator settings in their clinical practice.
Reliable assessment of respiratory drive and inspiratory 
breathing effort is key toward understanding the balance 
between harm and benefit of SB (28). In an experimental model 
of ARDS, high transpulmonary pressure generated by strong SB 
effort worsened lung injury even when plateau pressures were 
limited to less than 30 cm H
2
O (29). Other data also suggest that 
SB patients with high respiratory drive may develop a form of 
patient self-inflicted lung injury (30). The increase in transmu-
ral pulmonary vascular pressure swings caused by inspiratory 
effort may worsen vascular leakage. Other mechanisms that 
could contribute to harm caused by SB include the occurrence 
of occult breath stacking (31) and reverse triggering when large 
spontaneous diaphragmatic contractions can be triggered by 
the ventilator in heavily sedated, nonparalyzed patients (32).
Our study has several limitations. Data were collected once 
per day, and we did not collect hours of duration of MV modes. 
In addition to the set ventilatory mode, we compared actual RR 
with set RR to determine whether patients had SB. However, 
we cannot be certain that patients whose actual rate equals the 
set rate do not have SB. Limiting our analysis of patients in the 
C group to those who received neuromuscular blockade on the 
first 2 days showed similar results (data not shown). Further, 
the presence of triggering in an AC or partially assisted mode 
does not provide insight into the magnitude of inspiratory 
effort. The use of Vt as a surrogate marker for lung distension 
and inspiratory effort has limitations as discussed earlier.
Finally, because of the observational nature of the study, 
there are unmeasured confounders. In our belief, the obser-
vation that patients with no SB were sicker and had worse 
unadjusted outcomes may reflect a systematic clinicians’ bias 
toward the use of controlled ventilation in patients with higher 
ARDS severity. It remains unclear whether these sicker patients 
would have benefited from the maintenance of SB. This treat-
ment indication bias cannot be properly addressed apart from 
a randomized clinical study.
We believe further research using better markers of respira-
tory drive and effort is needed to address the question whether 
SB during MV is beneficial or harmful in patients with ARDS. 
Several techniques have been proposed, including airway 
occlusion pressure (P0.1), esophageal manometry, diaphragm 
electrical activity, or diaphragm ultrasound (33, 34). An ade-
quately powered prospective randomized clinical trial should 
be conducted to compare controlled MV with PSV in patients 
Figure 3. Distribution of tidal volume versus plateau pressure (means of day 1 and 2) for each patient for which these data are available. The limits for 
protective ventilation are defined as plateau pressure less than or equal to 30 cm H2O and tidal volume of less than or equal to 8 mL/kg of predicted 
body weight (PBW). SB = spontaneous breathing. C group represent patients with no SB activity and SB group represent patients with SB activity.
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with ARDS, stratified by severity and adjusting for all potential 
severity confounders.
In conclusion, in a large cohort of patients with ARDS, 
SB during MV on the first 2 days was apparent in more than 
half of patients and was associated with increased VFDs and 
shorter ICU stay in adjusted analysis, without an effect on hos-
pital mortality. Although these results support the use of SB in 
patients with ARDS independent of ARDS severity, the use of 
controlled ventilation indicates a bias toward use in patients 
with higher disease severity, and further analysis of our non-
randomized cohort is not able to address the potential intrinsic 
benefits or harms of SB during MV of ARDS patients.
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